Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis
Listen to this summary
The authors investigate the role of Asb2, a muscle-specific E3 ubiquitin ligase, in cardiac remodeling and heart failure, particularly its impact on mitochondrial function and autophagic flux. They find that Asb2 deficiency leads to cardiac hypertrophy and heart failure through impaired KIF11-mediated lysosomal distribution and autophagosome-lysosome fusion. Restoring Asb2 expression or inhibiting KIF11 can reverse these pathological changes, suggesting that targeting the Asb2-KIF11 axis may offer a therapeutic approach for chronic heart failure.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Circulation
View all →Sep 22, 2026 · Circulation
Real-World Experience With the Extravascular Implantable Cardioverter Defibrillator Through 1 Year: The Enlighten Post Approval Registry Study
Sep 22, 2026 · Circulation
Sotatercept Improves Right Heart Mechanics Despite Reduced Myocardial Contractility in Pulmonary Arterial Hypertension: A Prospective Exercise Hemodynamic Study
Sep 22, 2026 · Circulation
Prognostic Value of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve From a Large Nationwide Cohort
Sep 22, 2026 · Circulation
ALKBH5-Dependent m<sup>6</sup>A Demethylation Promotes Cardiac Aging Through SLC38A3 Reduction and Glutamine Metabolic Alteration
Sep 22, 2026 · Circulation
Novel mTORC1 Booster LAPTM4A Potentiates Pathological Cardiac Hypertrophy
Sep 21, 2026 · Circulation
Acute Coronary Syndrome in Kawasaki Disease From Infancy to Adulthood
More in Thoracic Surgery (Cardiothoracic Vascular Surgery)
View all →Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 22, 2026 · Lancet (London, England)
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


